DeepMed Research

The Case Comprehensive Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1826-01-01

Employees: 5K

Market Cap: -

Website: http://www.case.edu/cancer

Clinical Trials

Two Regimens of Docetaxel in Treating Patients Who Have Not Received Chemotherapy For Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Phase 2

Completed

Conditions: Lung Cancer

Interventions: Drug: docetaxel

First Posted Date: 2004-01-12

Last Posted Date: 2014-01-16

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 6

Registration Number: NCT00075374

Locations: 🇺🇸
Ireland Cancer Center, Cleveland, Ohio, United States

Vinorelbine and Celecoxib in Treating Women With Relapsed or Metastatic Breast Cancer

Phase 1

Terminated

Conditions: Breast Cancer

First Posted Date: 2004-01-12

Last Posted Date: 2020-07-27

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 6

Registration Number: NCT00075673

Locations: 🇺🇸
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

SU5416 in Treating Patients With Advanced Solid Tumors

Phase 1

Completed

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2003-12-17

Last Posted Date: 2010-06-11

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 19

Registration Number: NCT00005642

Locations: 🇺🇸
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Advanced Breast Cancer

Phase 1

Withdrawn

Conditions: Breast Cancer

First Posted Date: 2003-12-11

Last Posted Date: 2014-03-05

Lead Sponsor: Case Comprehensive Cancer Center

Registration Number: NCT00074139

Locations: 🇺🇸
Ireland Cancer Center, Cleveland, Ohio, United States

Gemcitabine and Carboplatin Followed By Docetaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Phase 3

Completed

Conditions: Lung Cancer

Interventions: Drug: carboplatin
Drug: docetaxel
Drug: gemcitabine hydrochloride

First Posted Date: 2003-12-11

Last Posted Date: 2010-08-16

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 17

Registration Number: NCT00074204

Locations: 🇺🇸
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas

Phase 2

Terminated

Conditions: Lymphoma

First Posted Date: 2003-09-24

Last Posted Date: 2011-01-17

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 6

Registration Number: NCT00003113

Locations: 🇺🇸
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

HER-2 Protein Vaccine in Treating Women With Breast Cancer

Phase 1

Completed

Conditions: Breast Cancer

First Posted Date: 2003-09-11

Last Posted Date: 2014-02-05

Lead Sponsor: Case Comprehensive Cancer Center

Registration Number: NCT00068614

Locations: 🇺🇸
Ireland Cancer Center, Cleveland, Ohio, United States

Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies

Not Applicable

Completed

Conditions: Lymphoma
Myelodysplastic/Myeloproliferative Diseases
Multiple Myeloma and Plasma Cell Neoplasm
Chronic Myeloproliferative Disorders
Leukemia
Myelodysplastic Syndromes

First Posted Date: 2003-09-11

Last Posted Date: 2020-07-27

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 10

Registration Number: NCT00068523

Locations: 🇺🇸
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Combination Chemotherapy in Treating Patients With AIDS-Related Hodgkin's Disease

Phase 2

Completed

Conditions: Lymphoma

First Posted Date: 2003-08-13

Last Posted Date: 2010-06-11

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 5

Registration Number: NCT00003114

Locations: 🇺🇸
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Radiolabeled Monoclonal Antibody in Treating Patients With Previously Treated Large Cell Lymphoma

Phase 1

Completed

Conditions: Lymphoma

First Posted Date: 2003-06-30

Last Posted Date: 2014-01-09

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 2

Registration Number: NCT00028613

Locations: 🇺🇸
Ireland Cancer Center, Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy